ArticleFrontiers in oncology2022

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.